SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech for less than cash value
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BulbaMan who wrote (123)9/16/2002 5:18:10 PM
From: BulbaMan  Read Replies (1) of 684
 
BVF Partners Acquires 144,000 More shares of Corvas International Inc. (CVAS)
DOW JONES NEWSWIRES
WASHINGTON -- BVF Partners L.P. purchased 144,000 more shares
of Corvas International Inc. (CVAS) common stock late last week,
according to a filing Monday with the Securities and Exchange
Commission.

BVF Partners purchased the shares Sept. 12 for $1.33 a share,
increasing its Corvas stock holdings to 4.6 million shares, the filing said.

Shares of Corvas recently traded at $1.34, down 3 cents or 2.2%.

Including the purchases on Sept. 12, BVF Partners has acquired a total
of 290,600 Corvas common shares since the beginning of the month.

Corvas is a biopharmaceutical company.

-By Robert L. Grant; Dow Jones Newswires; 202-393-7851;
robert.grant@dowjones.com

Updated September 16, 2002 3:45 p.m. EDT
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News